cancer

This March 12, 2019 photo provided by Brigitte Sagasser shows her in San Marcos, Calif. Sagasser, a participant in a federal study for rare cancers, seems to be benefitting from the treatment. Her tumors have been shrinking since starting the treatment a year ago for a rare type of ovarian cancer that defied surgeries, chemotherapy and hormone therapy. (Courtesy Brigitte Sagasser via AP)
April 01, 2019 - 12:34 pm
ATLANTA (AP) — People with rare cancers have been out of luck — not only do most lack good treatments but drug companies also don't pursue them because of small potential sales. Now, a federal study that pools these folks gives them strength in numbers and new options. The first results from this...
Read More
FILE - This Dec. 11, 2006 file photo shows a silicone gel breast implant in Irving, Texas. U.S. health officials are taking another look at the safety of breast implants, the latest review in a decades-long debate. At a two-day meeting that starts Monday, March 25, 2019, a panel of experts for the U.S. Food and Drug Administration will hear from researchers, plastic surgeons and implant makers, as well as from women who believe their ailments were caused by the implants. (AP Photo/Donna McWilliam, File)
March 25, 2019 - 9:30 pm
SILVER SPRING, Md. (AP) — Government medical advisers said Monday it's too soon to ban a type of breast implant that has recently been linked to a rare form of cancer, saying more information is needed to understand the problem. The Food and Drug Administration panel didn't recommend any immediate...
Read More
This undated photo provided by the Oregon Health and Science University in March 2019 shows a baby monkey named Grady, at two weeks old, born from an experimental technology that aims to help young boys undergoing cancer treatment preserve their future fertility. Scientists froze testicular tissue from a monkey that had not yet reached puberty, and later thawed it to produce sperm used for Grady’s conception. (OHSU via AP)
March 21, 2019 - 2:08 pm
WASHINGTON (AP) — Scientists are closing in on a way to help young boys undergoing cancer treatment preserve their future fertility — and the proof is the first monkey born from the experimental technology. More and more people are surviving childhood cancer, but nearly 1 in 3 will be left...
Read More
March 19, 2019 - 5:40 pm
SAN FRANCISCO (AP) — A jury in federal court in San Francisco has concluded that Roundup weed killer was a substantial factor in a California man's cancer. The unanimous verdict on Tuesday came in a trial that plaintiffs' attorneys said could help determine the fate of hundreds of similar lawsuits...
Read More
FILE - This Oct. 14, 2015 file photo shows the Food & Drug Administration campus in Silver Spring, Md. On Friday, March 8, 2019, the FDA approved Roche’s Tecentriq, the first cancer immunotherapy for treating an aggressive type of breast cancer. (AP Photo/Andrew Harnik, File)
March 08, 2019 - 6:26 pm
The U.S. Food and Drug Administration has approved the first immunotherapy drug for breast cancer. Swiss drugmaker Roche's Tecentriq was OK'd Friday for treating advanced triple-negative breast cancer, which accounts for about 15 percent of cases. It's to be given with chemotherapy, the standard...
Read More
In this Oct. 1, 2018, photo, moderator Alex Trebek speaks during a gubernatorial debate between Democratic Gov. Tom Wolf and Republican Scott Wagner in Hershey, Pa. Jeopardy!" host Trebek says he has been diagnosed with advanced -four pancreatic cancer. In a video posted online Wednesday, March 6, 2019, Trebek said he was announcing his illness directly to "Jeopardy!" fans in keeping with his long-time policy of being "open and transparent." (AP Photo/Matt Rourke)
March 06, 2019 - 8:09 pm
LOS ANGELES (AP) — "Jeopardy!" host Alex Trebek said he has been diagnosed with advanced pancreatic cancer but intends to fight the disease and keep on working. In a video posted online Wednesday, the 78-year-old said he was announcing his illness directly to "Jeopardy!" fans in keeping with his...
Read More
A scientist at the NY Genome Center in New York demonstrates equipment used in single-cell RNA analysis on Wednesday, Sept. 26, 2018. Until recently, trying to study key traits of cells from people and other animals often meant analyzing bulk samples of tissue, producing an average of results from many cell types. But scientists have developed techniques that let them directly study the DNA codes, and its chemical cousin RNA, the activity of genes and other traits of individual cells. (AP Photo/Malcolm Ritter)
March 04, 2019 - 6:29 am
NEW YORK (AP) — Did you hear what happened when Bill Gates walked into a bar? Everybody there immediately became millionaires — on average. That joke about a very rich man is an old one among statisticians. So why did Peter Smibert use it to explain a revolution in biology? Because it shows...
Read More
FILE - In this Nov. 16, 2018, file photo, Las Vegas Sands Corporation Chief Executive and Republican mega donor Sheldon Adelson, stands as he is recognized by President Donald Trump during a Medal of Freedom ceremony in the East Room of the White House in Washington. Casino magnate and GOP donor Adelson is not in good health and has not being at his company's offices in Las Vegas since around Christmas Day. Las Vegas Sands Corp. on Thursday, Feb. 28, 2019, did not immediately respond to a request for comment. Attorney James Jimmerson told the court the condition of the 85-year-old billionaire is dire. (AP Photo/Andrew Harnik, File)
March 01, 2019 - 7:54 pm
LAS VEGAS (AP) — Casino magnate and major GOP donor Sheldon Adelson is battling cancer, but industry analysts and his Las Vegas Sands Corp. on Friday said the gambling empire he founded and helms has the personnel to guide it through the health crisis. Their comments came a day after the company...
Read More
The logo of the Bayer company displayed at a company's building in Leverkusen, Germany, Wednesday, Feb. 27, 2019. ( Oliver Berg/dpa via AP)
February 27, 2019 - 4:42 am
BERLIN (AP) — Germany's Bayer AG, which bought Monsanto Co. last year, is underlining its determination to fight cases involving the U.S. company's Roundup weed-killer in the face of more than 11,000 lawsuits so far. In August, a San Francisco jury awarded a man $289 million after determining...
Read More
February 25, 2019 - 7:27 pm
SAN FRANCISCO (AP) — A jury in federal court in San Francisco will decide whether Roundup weed killer caused a California man's cancer in a trial starting Monday that plaintiffs' attorneys say could help determine the fate of hundreds of similar lawsuits. Edwin Hardeman, 70, is the second plaintiff...
Read More

Pages